Publication:
Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.

dc.contributor.authorBermúdez-Jiménez, Francisco José
dc.contributor.authorCarriel, Víctor
dc.contributor.authorBrodehl, Andreas
dc.contributor.authorAlaminos, Miguel
dc.contributor.authorCampos, Antonio
dc.contributor.authorSchirmer, Ilona
dc.contributor.authorMilting, Hendrik
dc.contributor.authorAbril, Beatriz Álvarez
dc.contributor.authorÁlvarez, Miguel
dc.contributor.authorLópez-Fernández, Silvia
dc.contributor.authorGarcía-Giustiniani, Diego
dc.contributor.authorMonserrat, Lorenzo
dc.contributor.authorTercedor, Luis
dc.contributor.authorJiménez-Jáimez, Juan
dc.date.accessioned2023-01-25T10:01:49Z
dc.date.available2023-01-25T10:01:49Z
dc.date.issued2017-12-06
dc.description.abstractDesmin (DES) mutations cause severe skeletal and cardiac muscle disease with heterogeneous phenotypes. Recently, DES mutations were described in patients with inherited arrhythmogenic right ventricular cardiomyopathy/dysplasia, although their cellular and molecular pathomechanisms are not precisely known. Our aim is to describe clinically and functionally the novel DES-p.Glu401Asp mutation as a cause of inherited left ventricular arrhythmogenic cardiomyopathy/dysplasia. We identified the novel DES mutation p.Glu401Asp in a large Spanish family with inherited left ventricular arrhythmogenic cardiomyopathy/dysplasia and a high incidence of adverse cardiac events. A full clinical evaluation was performed on all mutation carriers and noncarriers to establish clinical and genetic cosegregation. In addition, desmin, and intercalar disc-related proteins expression were histologically analyzed in explanted cardiac tissue affected by the DES mutation. Furthermore, mesenchymal stem cells were isolated and cultured from 2 family members with the DES mutation (1 with mild and 1 with severe symptomatology) and a member without the mutation (control) and differentiated ex vivo to cardiomyocytes. Then, important genes related to cardiac differentiation and function were analyzed by real-time quantitative polymerase chain reaction. Finally, the p.Glu401Asp mutated DES gene was transfected into cell lines and analyzed by confocal microscopy. Of the 66 family members screened for the DES-p.Glu401Asp mutation, 23 of them were positive, 6 were obligate carriers, and 2 were likely carriers. One hundred percent of genotype-positive patients presented data consistent with inherited arrhythmogenic cardiomyopathy/dysplasia phenotype with variable disease severity expression, high-incidence of sudden cardiac death, and absence of skeletal myopathy or conduction system disorders. Immunohistochemistry was compatible with inherited arrhythmogenic cardiomyopathy/dysplasia, and the functional study showed an abnormal growth pattern and cellular adhesion, reduced desmin RNA expression, and some other membrane proteins, as well, and desmin aggregates in transfected cells expressing the mutant desmin. The DES-p.Glu401Asp mutation causes predominant inherited left ventricular arrhythmogenic cardiomyopathy/dysplasia with a high incidence of adverse clinical events in the absence of skeletal myopathy or conduction system disorders. The pathogenic mechanism probably corresponds to an alteration in desmin dimer and oligomer assembly and its connection with membrane proteins within the intercalated disc.
dc.identifier.doi10.1161/CIRCULATIONAHA.117.028719
dc.identifier.essn1524-4539
dc.identifier.pmid29212896
dc.identifier.unpaywallURLhttps://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.028719
dc.identifier.urihttp://hdl.handle.net/10668/11883
dc.issue.number15
dc.journal.titleCirculation
dc.journal.titleabbreviationCirculation
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.page.number1595-1610
dc.pubmedtypeCase Reports
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectarrhythmogenic right ventricular dysplasia
dc.subjectdesmin
dc.subjectmutation
dc.subjectmyopathy, myofibrillar, desmin-related
dc.subjectventricular fibrillation
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshArrhythmias, Cardiac
dc.subject.meshCardiomyopathies
dc.subject.meshCell Differentiation
dc.subject.meshCells, Cultured
dc.subject.meshChild
dc.subject.meshDesmin
dc.subject.meshElectrocardiography
dc.subject.meshFemale
dc.subject.meshGenetic Predisposition to Disease
dc.subject.meshHeart Defects, Congenital
dc.subject.meshHeart Ventricles
dc.subject.meshHeredity
dc.subject.meshHeterozygote
dc.subject.meshHumans
dc.subject.meshMagnetic Resonance Imaging
dc.subject.meshMale
dc.subject.meshMesenchymal Stem Cells
dc.subject.meshMiddle Aged
dc.subject.meshMutation
dc.subject.meshMyocytes, Cardiac
dc.subject.meshPedigree
dc.subject.meshPhenotype
dc.subject.meshSpain
dc.subject.meshYoung Adult
dc.titleNovel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number137
dspace.entity.typePublication

Files